Shares in Grifols fell as much as over 40% on Tuesday, wiping $3.83 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the Spanish drugmaker ...

MADRID/BARCELONA (Reuters) -Shares in Grifols fell by 30% on Tuesday, wiping nearly $3 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the ...

Grifols shares have fallen by around 23% since Gotham City published its first report on Jan. 9, questioning the size of the company's debt, wiping around 2 billion euros ($2.15 billion) off its ...

Spanish pharmaceutical company Grifols said on Friday it filed a lawsuit in a U.S. court against the founder of short-seller fund Gotham City Research, Daniel Yu, and his company, seeking damages ...

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in New York. The complaint ...

Grifols shares nosedive 24% after Gotham City Research reveals potential accounting fraud. Short seller report casts doubt on Grifols' financial health, hinting at possibly worthless shares. Ready ...

There is no peace for Grifols, S.A. (NASDAQ:GRFS).Once again, the Spanish Plasma company is in the crosshairs of the short-selling fund Gotham City, which had already accused Grifols of cooking ...

BARCELONA/LONDON (Reuters) -Grifols told investors on Thursday it did not foresee any problem closing its $1.8 billion sale of a stake in Shanghai RAAS, despite a slump in its shares after a ...

Shares of Spanish multinational pharmaceutical company Grifols SA (ES:GRF) cratered over 30%, hitting a fresh 52-week low of €8.10 on January 9 following short seller Gotham City Research’s ...

Shares in Grifols fell as much as over 40% on Tuesday, wiping $3.83 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the Spanish drugmaker to ...

Shares in Grifols fell as much as over 40% on Tuesday, wiping $3.83 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the Spanish drugmaker to ...